Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
GlobalData on MSN2d
MicroAire closes deal to acquire adipose tissue biotech NEOSYADUS-based MicroAire Surgical Instruments has acquired NEOSYAD, a developer of technology for adipose tissue engineering.
A month’s supply of Ozempic is close to $1,000 without insurance ... Given the popularity and demand for semaglutide products ...
A month’s supply of Ozempic is close to $1,000 without insurance ... as well as medical devices that also originate from Denmark such as hearing aids, Naas notes there would be “tradeoffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback